Nuzenio

Ralinepag

Ralinepag news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Stronger EPS, Ralinepag Progress, and Buybacks Might Change The Case For Investing In United Therapeutics (UTHR) - simplywall.stsimplywall.st · Fri, 07 Aug 2026 11:53:06 GMT How Investors May Respond To United Therapeutics (UTHR) EPS Strength And Ralinepag’s Phase 3 Milestone - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:09:59 GMT United Therapeutics Corporation Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 22:13:31 GMT UTHR: Q2 2026 revenue was $783M, with record Tyvaso DPI growth and strong pipeline progress - TradingViewTradingView · Wed, 05 Aug 2026 10:35:30 GMT Is United Therapeutics (UTHR) Undervalued After Its Phase 3 Ralinepag Results? - simplywall.stsimplywall.st · Thu, 30 Jul 2026 16:27:53 GMT Lancet Results Show Ralinepag Cut Clinical Worsening by 55 Percent in Pulmonary Arterial Hypertension - Medical DailyMedical Daily · Thu, 30 Jul 2026 07:00:00 GMT United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Published in The Lancet - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 11:53:06 GMTStronger EPS, Ralinepag Progress, and Buybacks Might Change The Case For Investing In United Therapeutics (UTHR) - simplywall.st

Thu, 06 Aug 2026 20:09:59 GMTHow Investors May Respond To United Therapeutics (UTHR) EPS Strength And Ralinepag’s Phase 3 Milestone - Yahoo Finance

Wed, 05 Aug 2026 22:13:31 GMTUnited Therapeutics Corporation Q2 2026 Earnings Call Summary - Yahoo Finance

Wed, 05 Aug 2026 10:35:30 GMTUTHR: Q2 2026 revenue was $783M, with record Tyvaso DPI growth and strong pipeline progress - TradingView

Thu, 30 Jul 2026 16:27:53 GMTIs United Therapeutics (UTHR) Undervalued After Its Phase 3 Ralinepag Results? - simplywall.st

Thu, 30 Jul 2026 07:00:00 GMTLancet Results Show Ralinepag Cut Clinical Worsening by 55 Percent in Pulmonary Arterial Hypertension - Medical Daily

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

UTHR7 live mentions Phase4 live mentions Therapeutics3 live mentions Stronger EPS2 live mentions Ralinepag Progress2 live mentions Buybacks Might Change2 live mentions The Case For2 live mentions Investing In United2 live mentions EPS Strength And2 live mentions United Therapeutics Corporation2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ralinepag.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.